Pages that link to "Q53413829"

The following pages link to Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: a transgenic study for blast crisis of human CML. (Q53413829):

Displaying 20 items.

• The NH(2)-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl (Q33967112) (← links)
• Activation-induced cytidine deaminase accelerates clonal evolution in BCR-ABL1-driven B-cell lineage acute lymphoblastic leukemia (Q34168766) (← links)
• Models of chronic myeloid leukemia (Q34214855) (← links)
• Molecular biology of chronic myeloid leukemia (Q34246740) (← links)
• MicroRNA miR-125b causes leukemia (Q34411303) (← links)
• Loss of p53 impedes the antileukemic response to BCR-ABL inhibition (Q34585293) (← links)
• A novel mouse model identifies cooperating mutations and therapeutic targets critical for chronic myeloid leukemia progression (Q36080675) (← links)
• Role of Dok-1 and Dok-2 in leukemia suppression (Q36399814) (← links)
• BCR–ABL1 kinase-dependent alteration of mRNA metabolism: potential alternatives for therapeutic intervention (Q37836928) (← links)
• Potential mechanisms of disease progression and management of advanced-phase chronic myeloid leukemia (Q38139571) (← links)
• Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines? (Q38144200) (← links)
• Effects of a Particular Heptapeptide on the IFN-α-Sensitive CML Cells (Q40484034) (← links)
• Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors (Q40540288) (← links)
• Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia (Q42023841) (← links)
• Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia (Q42223517) (← links)
• Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms (Q42795736) (← links)
• p53 restoration kills primitive leukemia cells in vivo and increases survival of leukemic mice. (Q43249196) (← links)
• Usefulness of quantitative assessment of JunB gene expression as a marker for monitoring chronic myeloid leukemia patients undergoing imatinib therapy. (Q54565407) (← links)
• Chronic myeloid leukemia extramedullary blast crisis presenting as central nervous system leukemia: A case report (Q58567334) (← links)
• Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update (Q91812801) (← links)